Scientific Sessions

Track 1

COVID-19 Case Reports

Novel coronavirus 2019 (COVID-19) also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, non-segmented positive-sense RNA virus belonging to the beta-coronaviridae family. This virus is known to cause severe bilateral pneumonia and acute respiratory distress syndrome (ARDS) which can lead to difficulty breathing requiring mechanical ventilation and intensive care unit management.

Track 2

Novel Coronavirus COVID-19

The ongoing coronavirus disease 2019 (COVID-19) pandemic has disrupted every aspect of our life. The need to provide high-level care for an enormous number of patients with COVID-19 infection during this pandemic has impacted resourcing for and restricted the routine care of all non-COVID-19 conditions.

Track 3

Impact of COVID-19

The people living with rare disorders, who represent a marginalized group of the population even in a normal world, have not received enough attention that they deserve. Due to the pandemic situation, they have experienced (and experiencing) an extreme inadequacy of regular clinical services, counseling, and therapies they need, which have made their life more vulnerable and feel more marginalized. Besides, the clinicians, researchers, and scientists working on rare genetic diseases face extra challenges due to the pandemic.

Track 4

Clinical Trials on COVID-19

Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes. People volunteer to take part in clinical trials to test medical interventions including drugs, cells and other biological products, surgical procedures, radiological procedures, devices, behavioural treatments and preventive care.

Track 5

General Virology Rare Diseases

A virus is an obligate intracellular parasite, meaning that it can only survive within a host cell and depends on it for replication and metabolic processes, e.g., protein synthesis. Viruses can be classified based on their genome (DNA or RNA or other structural components, such as the Capsid, the envelope, and the viral receptor proteins (spikes). The viral replication cycle occurs within the host cell and involves attachment to and penetration of the host cell, uncoating of the nucleic acid, replication of the nucleic acid, synthesis of virus proteins, assembly of the components, and release of new viruses via budding or cell lysis.

Track 6

Veterinary Virology

Disease Transmitted from Animals to Humans. A zoonosis (zoonotic disease or zoonoses -plural) is an infectious disease that is transmitted between species from animals to humans (or from humans to animals).

Track 7

Medical Virology

Medical microbiology and virology (MMV) involve the diagnosis, treatment and prevention of the spread of infection in hospitals and the community. Both these specialties are laboratory-based, but make a major contribution to clinical infection management.

Track 8

Viral Oncology

Viral oncology is a subdivision of oncology,in these it is concerned with treatment of  human cancers /tumors with virus particles. Approximately 20% of all cancers worldwide results from chronic infections, in specific, up to 15% of human cancers is characterized by a viral aetiology with higher incidence in Developing Countries. 

Track 9

HIV, AIDS and other Emerging Viruses

 

The human immunodeficiency virus is a lentivirus that causes HIV infection and AIDS.HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies done to have a better approach, distinguish, or treat HIV/AIDS. Clinical trials are the predominant way to determine if new medical approaches to HIV/AIDS are safe and effective in people.
 

Track 10

Plant and Agricultural Virology

The epidemiology of plant virus diseases concerns the cyclical development of virus diseases within plant populations in time and space. Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects a wide range of plants, especially tobacco and other members of the family Solanaceae. In the viral life cycle, viral entry is the emergent stage of infection, as the virus invades with the host cell and intrudes viral material into the cell.

Track 11

Viral Biochemistry

A virus is an infectious, parasitic agent that can only replicate inside other host cells. All viruses have a genome and a capsid. A viral genome can be: Single stranded (ss) or double stranded (ds) DNA or RNA.

Track 12

Clinical Virology

Clinical Virology is subdivision of viral methodology which deals with clinical aspects of virus-induced clinical conditions. It includes the study of resistance of viruses in treatment antiviral by viral genome sequencing, viral pathogenesis and viral immunology. Clinical Virology mainly deals with cell cultures, serological, biochemical and molecular studies.

Track 13

Insect Virus and Fungal Virology

A fungal infection is also known as mycosis. Although most fungi are harmless to humans, some of them are capable of causing diseases under specific conditions. Fungi reproduce by releasing spores that can be picked up by direct contact or even inhaled.

Track 14

Viral Infections during Pregnancy

 viral infection of the cells at the maternal-fetal interface can affect placental function, which may result in pregnancy complications such as miscarriage, intrauterine growth restriction (IUGR), or preterm birth (PTB)

Track 15

Respiratory Viral Infections

Respiratory viral infections are a leading cause of disease and mortality. The severity of these illnesses can vary markedly from mild or asymptomatic upper airway infections to severe wheezing, bronchiolitis or pneumonia.

Track 16

Immunology and Vaccines

Viral immunology is simply the study of immune responses to viruses. A prolonged tissue-damaging effect resulting from an immune reaction against viruses is considered immunopathology. Such situations most commonly involve persistent viruses, which are themselves often mildly cytodestructive in the absence of an immune reaction.

Track 17

Bacterial Infectious Diseases

A bacterial infection is a proliferation of a harmful strain of bacteria on or inside the body. Bacteria can infect any area of the body. Pneumonia, meningitis, and food poisoning are just a few illnesses that may be caused by harmful bacteria.

Track 18

Parasitic Infectious Diseases

A parasitic disease, also known as parasitosis, is an infectious disease caused or transmitted by a parasite. Many parasites do not cause diseases as it may eventually lead to death of both organism and host. Parasites infecting human beings are called human parasites.

Track 19

Fungal Infectious Diseases

A fungal infection is also known as mycosis. Although most fungi are harmless to humans, some of them are capable of causing diseases under specific conditions. Fungi reproduce by releasing spores that can be picked up by direct contact or even inhaled

Track 20

Neuro Infectious Diseases

Neuroinfectious diseases are infections of the nervous system. This includes the brain, spinal cord and nerves. Neuroinfectious diseases typically result when the body's immune system is unable to fight off an invading pathogen or germ.

Track 21

Pulmonary and Chest Infections

A chest infection is an infection that affects your lungs, either in the larger airways (bronchitis) or in the smaller air sacs (pneumonia). There is a build-up of pus and fluid (mucus), and the airways become swollen, making it difficult for you to breathe. Chest infections can affect people of all ages.

Track 22

Urinary Tract Infections

A urinary tract infection (UTI) is an infection in any part of your urinary system — your kidneys, ureters, bladder and urethra. Most infections involve the lower urinary tract — the bladder and the urethra. Women are at greater risk of developing a UTI than are men.

Track 23

Gastrointestinal Infections

Gastrointestinal infections are viral, bacterial or parasitic infections that cause gastroenteritis, an inflammation of the gastrointestinal tract involving both the stomach and the small intestine. Symptoms include diarrhea, vomiting, and abdominal pain.

Track 24

Dental and Oral Infectious Diseases

Oral infections are some of the most common diseases in humans. The two most common oral infections are caries and periodontal disease. Dental caries is the most common chronic disease of childhood and is the biggest unmet health care need among America's children.

Track 25

Obstetrics and Gynecology Infectious Diseases

Infectious Diseases in Obstetrics and Gynecology related to infectious diseases in women's health. Topics include diagnosis and treatment of sexually transmitted diseases, urinary tract infections, and infections in pregnancy.

Track 26

Pediatric Infectious Diseases

Infections caused by viruses are universal during childhood and adolescence. Clinicians will regularly care for children and adolescents who present with infections caused by a wide number of viral pathogens. These infections have varied presentations. Many infections may have clinical presentations that are specific to the infecting virus but present differently, based on the age and immunocompetence of the patient.

Track 27

Animal Infectious Diseases

Viruses are smaller and simpler in construction than unicellular microorganisms, and they contain only one type of nucleic acid—either DNA or RNA—never both. As viruses have no ribosomes, mitochondria, or other organelles, they are completely dependent on their cellular hosts for energy production and protein synthesis. They replicate only within cells of the host that they infect

Track 28

Sexually Transmitted Infections

HIV (human immunodeficiency virus) is a virus that attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases. It is spread by contact with certain bodily fluids of a person with HIV, most commonly during unprotected sex (sex without a condom or HIV medicine to prevent or treat HIV), or through sharing injection drug equipment.

AIDS is the late stage of HIV infection that occurs when the body’s immune system is badly damaged because of the virus.

Track 29

Ebola and Zika Viral Infections

Ebola virus is associated with high mortality and a very high pregnancy or neonatal loss rate. Zika virus carries a risk of congenital Zika syndrome. Treatment of both is limited to management of symptoms; therefore prevention of transmission is critical to avoid adverse outcomes.

Track 30

Blood Stream Infections

Bloodstream infections include infective endocarditis, central venous catheter-associated bloodstream infections, primary bacteremia, and those with secondary bacteremia due to focal infections including abscesses, osteomyelitis, urinary tract infections, or pneumonia. Bloodstream infection is a major cause of morbidity and mortality despite the availability of broad spectrum and effective antimicrobials and major advances in supportive care.

Track 31

Microbiology and Immunology

Microbiology is the branch of biology dealing with the smallest of living things: bacteria, fungi, algae, protozoa, and viruses. Immunology is the study of the response of higher organisms to foreign substances, including microbes.

Track 32

Viral Infections and Recent Advancements

Viral infectious diseases represent an important portion of global public health concerns with thousands of deaths annually. From serious pandemics and highly contagious infections to common influenza episodes, clinical prognosis often relies on early detection of the infectious agent. Thus, effective identification of viral pathogens is needed to help prevent transmission, set up appropriate therapy, monitor response to treatment and lead to efficient disease management and control.

Track 33

Current research on Viral and Rare Diseases

The current study in virology involves the investigation of the mechanism of HIV replication and pathogenesis. Diseases like Alzheimer's disease and HIV-1-associated dementia. Some other research involves chronic and latent infections which are caused by viruses such as Retrovirus, Herpes simplex and the retrovirus, Epstein-Barr and Kaposi's sarcoma-associated herpes virus, scientists are also assessing viral-host interactions along with the viral induced cellular transformation mechanism. 

Track 34

Diagnosis of Viral Infectious Diseases

Diagnosis of any probable viral infection with the help of various tests such as, specific, assorted or conventional tests to identify the causative virus. Multiple methods are in use for laboratory diagnosis in probing the viral infections, including serology, viral culture, antigen detection, and nucleic acid detection. Due to various developments in the technology, we see high-end and quite impressive immunologic and molecular diagnostic tests are developed to provide more accurate results and to detect the viruses- type, number and to identify their pathogenicity as well.

Track 35

Antiviral Drug Discovery and Development

Viruses are intracellular pathogens that have evolved many devious strategies to evade host immune responses and, as a consequence, have plagued human health throughout history. Combating viral diseases with vaccines or antiviral drugs, or both, is a constant challenge. Even when successful strategies are discovered and employed, the high rate of genetic change exhibited by many viruses, particularly RNA viruses, often enables drug resistance or vaccine escape.

Track 36

Clinical Studies and Case Reports

In medicine, a case report is a detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient. Case reports may contain a demographic profile of the patient, but usually describe an unusual or novel occurrence.

Track 37

Rare Diseases and Drug Development

Viruses are intracellular pathogens that have evolved many devious strategies to evade host immune responses and, as a consequence, have plagued human health throughout history. Combating viral diseases with vaccines or antiviral drugs, or both, is a constant challenge. Even when successful strategies are discovered and employed, the high rate of genetic change exhibited by many viruses, particularly RNA viruses, often enables drug resistance or vaccine escape.

Track 38

Antibodies Engineering and Therapeutics

Viruses are intracellular pathogens that have evolved many devious strategies to evade host immune responses and, as a consequence, have plagued human health throughout history. Combating viral diseases with vaccines or antiviral drugs, or both, is a constant challenge. Even when successful strategies are discovered and employed, the high rate of genetic change exhibited by many viruses, particularly RNA viruses, often enables drug resistance or vaccine escape.

Track 39

Health Care Associated Infections

Health care-associated infections (HAIs) are infections people get while they're receiving health care for another condition. HAIs can happen in any health care facility, including hospitals, ambulatory surgical centers, end-stage renal disease facilities, and long-term care facilities

Track 40

Global Market on Virology and Infectious Diseases

The global virology market is estimated at $1693 million in 2017 and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is the leading market holder driven by world class healthcare substructure with technological advancement practice.

Watsapp